Actively Recruiting
Investigation of the Effects of Standard Rehabilitation Program and Inspiratory Muscle Training on lncRNA HOTAIR Expression in Patients With Rheumatoid Arthritis
Led by Saglik Bilimleri Universitesi · Updated on 2026-01-06
39
Participants Needed
1
Research Sites
23 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to explore the effects of adding respiratory muscle strengthening training to traditional respiratory rehabilitation for patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). It focuses on understanding how these exercise programs impact genetic changes, exercise capacity, shortness of breath, muscle strength, quality of life, and psychological state in these patients. The study also investigates the regulation of a specific long non-coding RNA, HOTAIR, which is linked to inflammation and joint damage in rheumatoid arthritis. Participants are assigned to one of three groups: a standard pulmonary rehabilitation program involving aerobic, resistance, and respiratory exercises; a similar program with added inspiratory muscle strengthening using a resistive device; or a control group with no intervention. Exercise sessions are supervised remotely twice weekly with an additional home-based session once a week, continuing for 3 months. The control group provides blood samples without engaging in exercise programs. During the study, participants will have assessments before and after the 12 weeks of intervention, including measuring lncRNA HOTAIR expression, respiratory muscle strength, exercise capacity via a 6-minute walk test, and quality of life questionnaires. Additional evaluations cover lung function tests, dyspnea scales, muscle strength, and physical activity levels. The study monitors changes in these outcomes to understand the effects of respiratory rehabilitation and muscle training on RA-ILD patients over the study period.
CONDITIONS
Brief Title
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with rheumatoid arthritis according to the ACR/EULAR 2010 classification criteria
- Diagnosis duration longer than 2 years
- Disease activity score (DAS28) below 5.1
- Voluntary participation in the study
- Presence of lung involvement
You will not qualify if you...
- Orthopedic deformities that may affect the treatment program
- Pregnancy
- Uncontrolled diabetes or heart disease
- Participation in a rehabilitation program within the last 6 months
- Body Mass Index (BMI) over 30
- Severe organ failure
- Recent acute coronary syndrome
- Presence of active infection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants undergo a 12-week exercise program, either a standard pulmonary rehabilitation program or pulmonary rehabilitation combined with inspiratory muscle training, or no intervention for the control group.
Remote supervised sessions 2 days a week and home exercises 1 day a week for exercise groups; no intervention visits for control group
Duration - Immediately after 12-week treatment period
Participants have assessments to measure lncRNA HOTAIR expression, respiratory muscle strength, exercise capacity, and quality of life after completing the treatment program.
1 visit (in-person)
Trial Site Locations
Total: 1 location
1
University of Health Sciences
Istanbul, Turkey, Turkey (Türkiye)
Actively Recruiting
Research Team
Z
Zeynep Betül ÖZCAN
E
Esra PEHLİVAN
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here